Skip to Main Content

Paper Details

Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition.
Blood
36
2015
Author NameAffiliation
Andrew J GentlesStanford University
M Ryan CorcesCancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Ravindra MajetiCancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
  • 1 - 3

Datasets

Release 1.2